Intervention therapy reduced CVD in patients with type 2 diabetes

Adams, Stacey L.; Edelman, Steven V.
March 2008
Endocrine Today;3/10/2008, Vol. 6 Issue 4, p10
The article reports on the results of the study published in "The New England Journal of Medicine" which states drug combination therapies and behavior modification can be beneficial to patients with type 2 diabetes at risk for cardiovascular disease (CVD). The study analyzes the effect of multifactorial intervention on death rates in type 2 diabetes patients at risk for CVD, and found that drug combinations and behavior modification sustained beneficial effects with respect to vascular complication and rates of death.


Related Articles

  • Plasma Homocysteine level and its clinical correlation with type 2 diabetes mellitus and its complications. Sonkar, Satyendra; Sonkar, Gyanendra; Soni, Deepika; Soni, Dheeraj; Usman, Kauser // International Journal of Diabetes in Developing Countries;Mar2014, Vol. 34 Issue 1, p3 

    Homocysteine (Hcys) has been implicated to be associated with diabetes and its complications. To study the association of plasma Hcys with diabetes complications (cardiovascular disease [CVD], cerebrovascular disease [CBVD], peripheral vascular disease [PVD], nephropathy, retinopathy and...

  • Adverse Reaction Research.  // Reactions Weekly;6/14/2008, Issue 1206, p5 

    The article discusses research on the cardiovascular effects of the drug rosiglitazone in patients with type 2 diabetes mellitus. It references a study posted on June 9, 2008 in the Web site of GlaxoSmithKline available at http://www.gsk.com. Researchers have reportedly observed that none of the...

  • Current Clinical Status and Vascular Complications among Patients with Type 2 Diabetes Mellitus at Tertiary Hospitals in Malaysia. Mun Chieng Tan; Ooi Chuan Ng; Teck Wee Wong; Hejar, Abdul Rahman; Joseph, Anthony // British Journal of Medicine & Medical Research;5/21/2014, Vol. 4 Issue 15, p2896 

    Objective: To assess the prevalence of diabetic vascular complications and cardiovascular risk factors control in type 2 diabetic patients at tertiary settings. Methods: This cross-sectional study was conducted among 313 patients diagnosed with type 2 diabetes mellitus (T2DM) at two tertiary...

  • Carotid stiffness and microalbuminuria in patients with type 2 diabetes. Wei-Wei Zhan; Yu-Hong Chen; Yi-Fei Zhang; Ying Zhu; Yan-Yan Lin; Xin-Ping Ren; Xiao-Ying Li; Yan-Ping Liu // Endocrine (1355008X);Jun2009, Vol. 35 Issue 3, p409 

    Abstract  Microalbuminuria is associated with higher cardiovascular mortality, especially in diabetics. But the direct association between microalbuminuria and vascular wall properties is still not clear. We investigated quantitative carotid stiffness (QCS) index in relation to...

  • Physical Activity, High-Sensitivity C-Reactive Protein, and Total and Cardiovascular Disease Mortality in Type 2 Diabetes. VEPSALAINEN, TEEMU; SOINIO, MINNA; MARNIEMI, JUKKA; LEHTO, SEPPO; JUUTILAINEN, AUNI; LAAKSO, MARKKU; RONNEMAA, TAPANI // Diabetes Care;Jul2011, Vol. 34 Issue 7, p1492 

    OBJECTIVE--Physical activity reduces high-sensitivity C-reactive protein (hs-CRP), cardiovascular disease (CVD), and total mortality in type 2 diabetic patients. However, it is not known whether the effects of physical activity on mortality depend on the levels of hs-CRP in patients with type 2...

  • Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes. Giorda, Carlo B.; Avogaro, Angelo; Maggini, Marina; Lombardo, Flavia; Mannucci, Edoardo; Turco, Salvatore; Alegiani, Stefania Spila; Raschetti, Roberto; Velussi, Mario; Ferrannini, Ele // Diabetes Care;Nov2008, Vol. 31 Issue 11, p2154 

    OBJECTIVE-- The purpose of this study was to assess incidence of and risk factors for recurrent cardiovascular disease (CVD) in type 2 diabetes. RESEARCH DESIGN AND METHODS-- We estimated the incidence of recurrent cardiovascular events in type 2 diabetic patients, aged 40-97 years, followed by...

  • The Effect of Sulphonylureas on the Microvascular and Macrovascular Complications of Diabetes. Partha Kar // Cardiovascular Drugs & Therapy;Jun2008, Vol. 22 Issue 3, p207 

    Abstract Introduction  Type 2 diabetes mellitus is a chronic progressive disease that is characterised by hyperglycaemia and is associated with an increased risk of the development of microvascular complications, such as retinopathy, nephropathy and neuropathy, and cardiovascular disease....

  • Achieving Glycemic Goals with Vildagliptin. Pratley, R. E.; Schweizer, A.; Couturier, A.; Dejager, S. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA134 

    The ADA recommends a target A1C <7.0% to minimize risk of microvascular complications in patients (pts) with type 2 diabetes (T2DM), but a minority achieve this goal. Vildagliptin is a potent and selective DPP-4 inhibitor that improves glycemic control by increasing both α- and β-cell...

  • Understanding and Managing Insulin Resistance in Type 2 Diabetes.  // Pharmacy Today;Sep2004, Vol. 10 Issue 9, special section p1 

    The article reports that the prevalence of type 2 diabetes is rising at an alarming rate, constituting a global public health crisis. Insulin resistance is now recognized as a core defect underlying both type 2 diabetes and cardiovascular disease. The prevalence of insulin resistance is rising...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics